Since the initial reports of coronavirus disease 2019 (COVID-19) in China in late 2019,
infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have …

Neuropilin-1 (NRP-1), a member of a family of signaling proteins, was shown to serve as an
entry factor and potentiate SARS Coronavirus 2 (SARS-CoV-2) infectivity in vitro. This cell …

Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult
patients. The spectrum of neurologic involvement in children and adolescents is unclear …

Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Objectives To assess the frequency and characteristics of headache in patients with COVID-
19 and whether there is an association between headache and anosmia and ageusia …

Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …

Entering the third year into the pandemic, overwhelming evidence demonstrates that
Coronavirus disease 2019 (COVID-19) infection is a systemic illness, often with involvement …

The clinical picture of coronavirus disease 2019 (COVID-19) in various target organs has
been extensively studied and described. However, relatively little is known about the …

Pathology studies of SARS-CoV-2 Omicron variants of concern (VOC) are challenged by the
lack of pathogenic animal models. While Omicron BA. 1 and BA. 2 replicate in K18-hACE2 …

A series of cases with rare thromboembolic incidents including cerebral sinus vein
thrombosis (some of them fatal) and concomitant thrombocytopenia occurring shortly after …